Seasonal variation of pharmaceutically active compounds in surface (Tagus River) and tap water (Central Spain)
Y Valcárcel1, S González Alonso, J L Rodríguez-Gil
1Department of Preventive Medicine, Public Health, Immunology and Medical Microbiology, Faculty of Health Science, Rey Juan Carlos University, Avda. Atenas s/n. Alcorcón, 28922, Madrid, Spain. yolanda.valcarcel@urjc.es
Abstract:
Numerous studies have shown the presence of pharmaceutically active compounds (PhACs) in different environmental compartments, for example, in surface water or wastewater ranging from nanograms per litre to micrograms per litre. Likewise, some recent studies have pointed to seasonal variability, thus indicating that PhAcs concentrations in the aquatic environment may depend on the time of year. This work intended to find out (1) whether Tagus fluvial and drinking water were polluted with different groups of PhACs and (2) if their concentrations differed between winter and summer seasons. From the 58 substances analysed, 41 were found belonging to the main therapeutic groups. Statistical differences were seen for antibacterials, antidepressants, anxiolytics, antiepileptics, and cardiovascular drugs, with higher concentrations being detected in winter than in summer. These results might indicate that the PhACs analysed in this study undergo lower environmental degradation in winter than in summer. In order to confirm these initial results, a continuous monitoring should be performed especially on those PhACs that either because of an elevated consumption or an intrinsic chemical persistence are poorly degraded during winter months due to low temperatures and solar irradiation. It is especially important to identify which of these specific PhACs are in order to recommend their substitution by equally effective and safe substances but also environmentally friendly.
Related Concept Videos
Therapeutic Drug Monitoring: Drug Analysis Methods
Measurement of Bioavailability: Pharmacokinetic Methods
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Drug Concentrations: Measurements
Plasma —...
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Measurement of Bioavailability: Pharmacodynamic Methods


